Cargando…
Co-delivery of Salinomycin and Curcumin for Cancer Stem Cell Treatment by Inhibition of Cell Proliferation, Cell Cycle Arrest, and Epithelial–Mesenchymal Transition
Malignant cancer is a devastating disease often associated with a poor clinical prognosis. For decades, modern drug discoveries have attempted to identify potential modulators that can impede tumor growth. Cancer stem cells however are more resistant to therapeutic intervention, which often leads to...
Autores principales: | Zhao, Yongmei, Wang, Kaikai, Zheng, Yuanlin, Zeng, Xiaobao, Lim, Yi Chieh, Liu, Tianqing |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7843432/ https://www.ncbi.nlm.nih.gov/pubmed/33520933 http://dx.doi.org/10.3389/fchem.2020.601649 |
Ejemplares similares
-
Salinomycin repressed the epithelial–mesenchymal transition of epithelial ovarian cancer cells via downregulating Wnt/β-catenin pathway
por: Li, Rui, et al.
Publicado: (2017) -
Curcumin Inhibits Proliferation and Epithelial-Mesenchymal Transition in Lens Epithelial Cells through Multiple Pathways
por: Liu, Huijun, et al.
Publicado: (2020) -
Salinomycin enhances doxorubicin sensitivity through reversing the epithelial-mesenchymal transition of cholangiocarcinoma cells by regulating ARK5
por: Yu, Z., et al.
Publicado: (2017) -
Epithelial to Mesenchymal Transition induces cell cycle arrest and parenchymal damage in renal fibrosis
por: Lovisa, Sara, et al.
Publicado: (2015) -
Salinomycin induces cell death and differentiation in head and neck squamous cell carcinoma stem cells despite activation of epithelial-mesenchymal transition and Akt
por: Kuo, Selena Z, et al.
Publicado: (2012)